Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Given Consensus Rating of “Moderate Buy” by Analysts
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1 year price objective among […]
More Stories
Love is Blind Couple, Chelsea and Kwame are Separating After 4 years Together
Yes, you heard it right. The famous couple from season 4 of Love is Blind is parting ways. The couple...
Netflix’s Romantic Drama, Forever Season 2 is Returning
Forever starring Lovie Simone is returning for its second season soon. Want to know more about the series details? Keep...
Popular Movies of Jason Momoa Movies on Netflix
Want to watch the older but popular movies of Jason Momoa? Here, in this blog, I have mentioned some of...
Netflix’s 10 Best Documentaries in 2026 That You Must Watch
There are tons of documentaries released in the blink of an eye in 2026. All these documentaries are based on...
Jason Biggs and Jenny Mollen Split After 18 Years of Marriage
Shocking news! Jason and his wife, Mollen, have separated after almost two decades together. What happened to the famous Hollywood...
Why Does Netflix Remove Shows? List of Shows Being Removed in 2026
Curious, why does Netflix remove shows from its library? There are several points that Netflix keeps in mind while removing...